Specialists from the Johns Hopkins, Duke Univ. and Roswell Park Cancer Inst. have made major progress in prostate cancer treatment after a scientific study conducted on two hundred patients found that the blood vessel obstructing medication known as tasquinimod slackened the rate at which the condition progressed. Tasquinimod is additionally dubbed as the angiogenesis-resistant medication which wrings out blood circulation to the prostate tumors by hampering growth of novel blood vessels. All tumors require extensive nets of blood vessels for supplying nutrient forms. The multi-center studies conducted at 7 institutes inclusive of John Hopkins, registered people with prostate cancer among whom the condition had metastasized. They were given a single, day-to-day tablet tasquinimod to be  [...]

New-fangled study findings of a Phase I-II of trial drug MDV3100 has shown potential in being a safe and effectual treatment for prostate cancer in patients having an aggressive type of the disease, castration-resistant prostate cancer or CRPC - a hormone refractory condition. Study outcomes demonstrate that MDV3100 could not merely shrivel tumors, but additionally lowered serum levels of PSA (prostate-specific antigen), a tumor marker. It also assisted in stabilizing the cancer which had metastasized to bone, soft tissues and diminished the tumor cell count that circulated in the blood. Howard Scher, MD, head of Genitourinary Oncology Service who helmed the study stated that they were buoyant on seeing anti-tumor activity among males in whom prostate cancer had metastasized to other  [...]

Prostate Cancer is the widespread cancer form in men that occurs due to the uncontrollable alteration and growth of the healthy cells present in the prostate leading to a mass formation known as tumor. Adenocarcinomas – the cancer developing in the glandular tissue constitute above ninety-five percent of all the prostate cancers. An atypical form of prostate cancer called the neuroendocrine or small cell anaplastic cancer has a tendency of spreading early, however generally does not create the PSA or prostate-specific antigen. Facts on Prostate Cancer An estimate of above twenty-seven thousand fatalities in men due to prostate cancer has occurred in 2009, however the fatality rate continues to be above two folds as elevated among black males in comparison to the white males. Mostly,  [...]

Prostate Cancer is a cancerous tumor originating in the prostate glands and the second prevalent reason for cancer fatalities among males. As the precise reasons leading to prostate cancer are yet unclear, the specific ways of averting prostate cancer is still fuzzy. The below mentioned factors could increase a man’s chances of getting prostate cancers: Age Aging is observed to be directly proportional to the risk of developing prostate cancer, with risk swiftly soaring subsequent to fifty years of age. Above eighty percent of the prostate cancer cases are diagnosed among sixty-five years and above aged males. Ethnicity Afro-American males are at increased likelihood of developing prostate cancers in comparison to fair-skinned males. Such males are additionally more prone to developing  [...]

Prostate Cancer is the prevalent form of cancer affecting males which originates due to the unrestrained growth of the cells present in the prostate gland. Stages of Prostate Cancer The general staging involves the three categories, namely: T – The size of the primary tumor. N- If the cancer has metastasized to the adjacent lymph nodes. M- The appearance or non-appearance of remote metastasis. All these three are taken into consideration alongside the Gleason score. There are four groups for illustrating the local size of the prostate tumor that ranges between T1 to T4 with majority of them also having sub-groupings. T1 The tumor could not be felt during the DRE exam or viewed during transrectal ultrasound imaging. T1a The cancer has been accidentally detected at  [...]

Annually nearly thirty-five thousand men are detected with prostate cancer in the United Kingdom and more than ten thousand face fatalities due to the disease. The disease is known to affect the small gland that fits around the urethra and is responsible for the production of seminal fluid. Being treated early plays a decisive role. Nearly 98% of men that are detected with the cancer that has not metastasized beyond the gland could have a life expectancy rate of 5 years and more. This survival rate plummets to 30% when the cancer has metastasized. The diagnostic and treatment options for prostate cancer in its initial stages are stated below. Active Surveillance Active Surveillance generally translates to getting a PSA test done. The PSA test is conducted for checking any rise  [...]